Point72 Asia Singapore Pte. Ltd. Has $36,000 Stock Holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Point72 Asia Singapore Pte. Ltd. trimmed its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 64.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 910 shares of the company’s stock after selling 1,631 shares during the period. Point72 Asia Singapore Pte. Ltd.’s holdings in Acadia Healthcare were worth $36,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Lindbrook Capital LLC boosted its stake in shares of Acadia Healthcare by 1,342.0% during the 4th quarter. Lindbrook Capital LLC now owns 721 shares of the company’s stock worth $29,000 after buying an additional 671 shares during the last quarter. Blue Trust Inc. lifted its stake in Acadia Healthcare by 69.4% in the fourth quarter. Blue Trust Inc. now owns 842 shares of the company’s stock valued at $33,000 after acquiring an additional 345 shares during the last quarter. Nisa Investment Advisors LLC lifted its stake in Acadia Healthcare by 40.7% in the fourth quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company’s stock valued at $41,000 after acquiring an additional 301 shares during the last quarter. Signaturefd LLC lifted its stake in Acadia Healthcare by 460.6% in the fourth quarter. Signaturefd LLC now owns 1,222 shares of the company’s stock valued at $48,000 after acquiring an additional 1,004 shares during the last quarter. Finally, Quadrant Capital Group LLC lifted its stake in Acadia Healthcare by 287.1% in the fourth quarter. Quadrant Capital Group LLC now owns 1,258 shares of the company’s stock valued at $50,000 after acquiring an additional 933 shares during the last quarter.

Wall Street Analyst Weigh In

A number of analysts have commented on the stock. Bank of America cut their price target on shares of Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating for the company in a research note on Friday, February 28th. KeyCorp cut their price target on shares of Acadia Healthcare from $65.00 to $55.00 and set an “overweight” rating for the company in a research note on Wednesday, May 14th. Barclays cut their price target on shares of Acadia Healthcare from $35.00 to $28.00 and set an “equal weight” rating for the company in a research note on Wednesday, May 14th. Guggenheim began coverage on shares of Acadia Healthcare in a research report on Wednesday, April 9th. They issued a “buy” rating and a $36.00 price objective on the stock. Finally, Mizuho dropped their price objective on shares of Acadia Healthcare from $37.00 to $32.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 14th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and six have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Acadia Healthcare presently has a consensus rating of “Moderate Buy” and a consensus target price of $47.94.

Acadia Healthcare Price Performance

NASDAQ:ACHC opened at $25.08 on Tuesday. Acadia Healthcare Company, Inc. has a 52 week low of $20.36 and a 52 week high of $82.41. The firm has a market cap of $2.31 billion, a price-to-earnings ratio of 8.22, a P/E/G ratio of 1.46 and a beta of 1.01. The firm’s 50-day simple moving average is $26.12 and its 200 day simple moving average is $35.37. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Monday, May 12th. The company reported $0.40 EPS for the quarter, topping analysts’ consensus estimates of $0.35 by $0.05. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The business had revenue of $770.51 million for the quarter, compared to analyst estimates of $769.90 million. During the same period last year, the firm earned $0.84 earnings per share. Acadia Healthcare’s revenue for the quarter was up .3% compared to the same quarter last year. As a group, sell-side analysts predict that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.